(a) What are zero disease concept and herd immunity? Discuss in detail about chemoprophylaxis. (20 marks)

(b) Discuss the various methods of Ghee manufacture along with their merits and demerits. Write down the FSSAI and Agmark standards of Ghee. (1

Question

(a) What are zero disease concept and herd immunity? Discuss in detail about chemoprophylaxis. (20 marks)

(b) Discuss the various methods of Ghee manufacture along with their merits and demerits. Write down the FSSAI and Agmark standards of Ghee. (15 marks)

(c) Discuss the epidemiological principles, methods of investigation and control of food-borne diseases. (15 marks)

UPSC Answer Check · Accepted Answer

The directive 'discuss' requires a comprehensive, analytical treatment with balanced coverage across all three sub-parts. Allocate approximately 40% of time/words to part (a) given its 20 marks, and roughly 30% each to parts (b) and (c). Structure with a brief introduction highlighting interconnected themes (disease prevention, food safety, public health), followed by dedicated sections for each sub-part with clear sub-headings, and conclude with integrated insights on One Health approach linking animal disease control to food safety.
- Part (a): Zero disease concept (eradication vs. elimination, regional examples like FMD-free zones), herd immunity threshold calculation (R0-based), and chemoprophylaxis details (antibiotics, antiparasitics, ionophores with specific examples like tetracycline for anaplasmosis, decoquinate for coccidiosis)
- Part (a): Critical analysis of chemoprophylaxis limitations: antimicrobial resistance (AMR), withdrawal periods, residue concerns, and regulatory frameworks (Veterinary Council of India guidelines)
- Part (b): Ghee manufacturing methods: desi/direct cream (khoa), creamery butter method, pre-stratification method, and continuous (centrifugal) process with technical merits/demerits for each
- Part (b): FSSAI standards (FSS Regulation 2011: moisture max 0.3%, FFA max 0.4%, BR reading 40-43 at 40°C) and Agmark grades (Grade A vs. B with specific analytical constants)
- Part (c): Epidemiological principles: web of causation, iceberg concept, dose-response relationships for food-borne pathogens; investigation methods: cohort, case-control, case-series studies with outbreak investigation steps
- Part (c): Control strategies: HACCP implementation in dairy/meat processing, hazard analysis, critical control points, and specific Indian examples (Salmonella in poultry, Listeria in soft cheeses, Brucella in raw milk)

Dimension	Weight	Max marks	Excellent	Average	Poor
Demand-directive understanding	20%	10	Demonstrates nuanced understanding of 'discuss' by presenting balanced arguments, critical evaluation, and interconnections across all three parts—linking disease prevention (a) to food safety outcomes (c) and quality standards (b); avoids mere description	Addresses all parts with basic discussion but treats them in isolation; limited critical engagement or synthesis between disease control and food safety themes	Misinterprets directive as 'list' or 'define'; provides fragmented, descriptive content without analysis; misses interconnections between sub-parts entirely
Content depth & accuracy	25%	12.5	Precise technical accuracy: for (a) calculates herd immunity threshold correctly, names specific chemoprophylactic agents with doses; for (b) details temperature-time parameters for ghee methods; for (c) applies epidemiological study designs correctly with outbreak investigation protocols	Generally correct information but lacks specificity—generic drug names without examples, approximate standards without numerical values, confused study design applications	Significant factual errors: confuses sterilization with pasteurization, misstates FSSAI limits, applies case-control when cohort is appropriate, or invents non-existent standards
Structure & flow	20%	10	Clear tripartite structure with explicit sub-headings (a), (b), (c); logical progression within each part (concept → application → limitations/standards); smooth transitions between epidemiological principles and practical control measures; integrated conclusion	Identifiable structure but uneven weighting—overlong on (a), rushed (b) and (c); or poor internal organization with mixed content between parts; missing or weak conclusion	No discernible structure; stream-of-consciousness writing; missing sub-part labels; incomplete coverage—one or more parts substantially omitted or merged incoherently
Examples / case-law / data	20%	10	Rich, contemporary Indian examples: for (a) cites India's FMD control programme, NADCP; for (b) references Amul's continuous ghee process, state-specific variations (Nandini, Verka); for (c) details specific outbreaks (Delhi Salmonella 2017, Listeria in Kerala 2018) with attack rates, case-fatality data	Generic or outdated examples; international references without Indian context; mentions programmes without specifics (e.g., 'various government schemes'); no quantitative outbreak data	No examples or irrelevant ones; confuses programmes (e.g., NADCP with NLM); fictional outbreak scenarios; no awareness of FSSAI enforcement cases or Agmark certification process
Conclusion & analytical edge	15%	7.5	Synthesizes all three parts through One Health lens: connects chemoprophylaxis AMR concerns to food-borne disease emergence, quality standards to disease prevention; offers forward-looking recommendations (precision livestock farming, blockchain traceability, strengthened FSSAI-state coordination)	Summarizes main points without synthesis; generic conclusion on 'need for more research'; no policy recommendations or future directions	No conclusion; or abrupt ending with unrelated statement; purely repetitive summary without analytical value; contradictory final remarks

(a) What are zero disease concept and herd immunity? Discuss in detail about chemoprophylaxis. (20 marks) (b) Discuss the…

Directive word: Discuss

How this answer will be evaluated

Approach

Key points expected

Evaluation rubric

Practice this exact question

More from Animal Husbandry & Veterinary Science 2021 Paper II